The institutional cluster is dominated by passive/index funds (Fidelity, BlackRock, Geode) likely reflecting IPO-related index inclusion rather than an active fundamental thesis. With no insider buying and a widening net loss, the accumulation is not a strong directional signal. Monitor for insider open-market purchases or a Phase 2b catalyst update to confirm conviction.
Executive Summary
Five major institutional investors initiated new positions in Avalyn Pharma during Q2 2026, accumulating $296.9M in total holdings. The cluster is dominated by mega-passive managers (Fidelity, BlackRock, Geode) alongside Citadel and Jennison Associates, suggesting the moves are likely driven by index inclusion or passive rebalancing following Avalyn's IPO, rather than a fundamental activist thesis. The Q2 earnings filing (5 days ago) showed a widening net loss of $28.9M and no near-term revenue catalysts, with the MIST Phase 2b topline data not expected until H2 2027, which tempers the bullish signal from the institutional accumulation.
Key Financial Metrics
Institutional Positions
Net institutional flow: $296.9M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Fidelity | NEW | +0% | $192.1M | $192.1M |
| BlackRock | NEW | +0% | $32.2M | $32.2M |
| Citadel | NEW | +0% | $31.6M | $31.6M |
| Jennison Associates | NEW | +0% | $26.8M | $26.8M |
| Geode | NEW | +0% | $14.3M | $14.3M |
Key Facts
- 5 institutions initiated new positions totaling $296.9M in Q2 2026
- Fidelity led with a $192.1M new position (5.84M shares)
- BlackRock ($32.2M), Citadel ($31.6M), Jennison ($26.8M), and Geode ($14.3M) also initiated
- No institutional sellers in the cluster
- Q2 2026 earnings showed a net loss of $28.9M, widening from $20.2M a year ago
- MIST Phase 2b topline data expected H2 2027; cash of $413.5M funds operations into 2029
- No open-market insider buying in the window (confluence score 38/100 — institutions only)
Financial Impact
5 institutions accumulated $296.9M in new positions, representing approximately 17.5% of the $1.7B market cap
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound
- Passive-dominated cluster (3 of 5 funds are mega-passive) weakens the signal
- No near-term revenue or catalyst until H2 2027
Market Snapshot
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-AVLN-2026-Q2 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 21, 2026 5w ago | Press Release | $31.62 $28.32 | ▼ −10.44% | ▼ −9.42% | — |
Aug 16, 2026 10w ago | Institutional Cluster | $38.25 $37.69 | ▼ −1.46% | ▼ −0.27% | — |
Aug 12, 2026 10w ago | 8-K | $37.38 $38.97 | ▲ +4.25% | ▲ +4.70% | — |
Aug 12, 2026 10w ago | Press Release | $37.38 $38.97 | ▲ +4.25% | ▲ +4.70% | — |
Jun 17, 2026 18w ago | 8-K | $29.31 $30.09 | ▲ +2.66% | ▲ +3.70% | — |
Jun 17, 2026 18w ago | Press Release | $29.31 $30.09 | ▲ +2.66% | ▲ +3.70% | — |
Jun 3, 2026 20w ago | 8-K | $26.40 $28.53 | ▲ +8.07% | ▲ +11.89% | — |
May 5, 2026 24w ago | Press Release | $27.71 $29.90 | ▲ +7.90% | ▲ +6.77% | — |
May 1, 2026 25w ago | Insider Cluster | $29.07 $29.57 | ▲ +1.72% | ▼ −1.25% | — |
May 1, 2026 25w ago | Insider Cluster | $29.07 $29.57 | ▲ +1.72% | ▼ −1.25% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers